Pharma vs Tech vs Oil: Which Industry Spends the Most on Lobbying?
Published April 6, 2026 · Senate LDA disclosure data
Three industries dominate the public conversation about corporate lobbying: pharmaceuticals, technology, and energy. But which actually spends the most? The answer depends on what you measure — total dollars, growth rate, or lobbying intensity per company.
Head-to-Head Comparison
| Industry | Organizations | Total Spend | Avg per Org |
|---|---|---|---|
| Pharmaceutical & Health Products | 34 | $566.7M | $16.7M |
| Technology & Internet | 47 | $673.3M | $14.3M |
| Energy & Natural Resources | 35 | $408.7M | $11.7M |
Pharma: The Established Heavyweight
Pharmaceutical lobbying is the most mature of the three sectors. The industry has spent billions over the past two decades defending against drug pricing legislation, shaping FDA approval processes, and influencing Medicare and Medicaid policy. PhRMA, the industry trade group, consistently ranks among the top 5 overall lobbying spenders in Washington.
Key pharma lobbying issues: drug pricing reform, patent policy, FDA regulation, Medicare Part D, biosimilar competition, and increasingly, AI in drug discovery and clinical trials.
Tech: The Fastest-Growing Force
Technology lobbying has grown more than any other sector over the past decade. What was once a relatively small lobbying presence has exploded as Congress and regulators target AI, antitrust, privacy, and content moderation. Major tech companies now maintain lobbying operations that rival the largest pharma and energy companies.
Key tech lobbying issues: AI regulation, antitrust enforcement, data privacy, Section 230, cryptocurrency, H-1B visas, and cybersecurity standards.
Oil and Energy: Fighting on Defense
Energy lobbying is heavily concentrated among a few major companies and the American Petroleum Institute. Unlike pharma (which lobbies to maintain favorable policy) and tech (which lobbies to prevent new regulation), energy companies increasingly lobby defensively — against emission standards, carbon taxes, and renewable energy subsidies.
Key energy lobbying issues: environmental regulation, carbon emission standards, drilling permits, pipeline approvals, renewable energy policy, and energy subsidies.
The Hidden Giant: Trade Associations
All three sectors are outspent by trade associations like the US Chamber of Commerce, National Association of Realtors, and Business Roundtable, which lobby across every issue area. For the full industry breakdown, see our industry comparison rankings.
Frequently Asked Questions
Which industry spends the most on lobbying?
Among the three most-discussed sectors, the pharmaceutical industry has historically spent the most on federal lobbying, followed by technology and energy. However, trade associations — which represent companies across all industries — collectively outspend any single sector.
How much does Big Pharma spend on lobbying?
The pharmaceutical and health products industry spends hundreds of millions annually on federal lobbying. Major spenders include PhRMA (the industry trade group), Pfizer, Johnson & Johnson, AbbVie, and Merck. Drug pricing legislation is consistently the top lobbying issue for this sector.
How much does the oil industry spend on lobbying?
The energy and natural resources sector spends tens of millions annually on federal lobbying, with ExxonMobil, Chevron, and the American Petroleum Institute among the largest spenders. Key issues include environmental regulation, carbon emission standards, drilling permits, and energy subsidies.
Why is tech lobbying growing faster than pharma or oil?
Tech lobbying has grown fastest because the industry faces an expanding set of regulatory fronts: AI regulation, antitrust enforcement, data privacy, content moderation (Section 230), and cryptocurrency regulation. Each new issue requires additional lobbying resources, while pharma and energy face more established regulatory frameworks.
About This Data
Industry spending data from Senate LDA filings. See our methodology for classification details.